David Fogelman, MD | Boston Children's Hospital

David Fogelman | Medical Services

Specialties

Cerebral Palsy

Programs & Services

Languages

English

David Fogelman | Education

Medical School

Mount Sinai School of Medicine

2009, New York, NY

Internship

Columbia University, St. Luke’s-Roosevelt Hospital Center

2010, New York, NY

Residency

Spaulding Rehabilitation Hospital

2013, Boston, MA

Fellowship

Rehabilitation Institute of Chicago

2015, Chicago, IL

David Fogelman | Certifications

American Board of Physical Medicine and Rehabilitation (General)
American Board of Physical Medicine and Rehabilitation (Pediatric Rehabilitation Medicine)

David Fogelman | Professional History

David Fogelman, MD began his professional career in engineering school and learned a lot about how to look at the world in terms of cause and effect. He worked in R&D for a Fortune 500 technology company for a few years after college before leaving the field for medical school. Having an engineer’s mind and a doctor’s training really helps him efficiently find what he can do best for his patients and colleagues.

David Fogelman | Media

Caregiver Profile

Meet Dr. David Fogelman

David Fogelman | Publications

Growth Attenuation Therapy: Ongoing Ethical and Practical Challenges 20 Years Post Ashley. Am J Bioeth. 2025 May 23; 1-9. View Growth Attenuation Therapy: Ongoing Ethical and Practical Challenges 20 Years Post Ashley. Abstract
Association between lower limb spasticity and cryptorchidism in males with cerebral palsy. Dev Med Child Neurol. 2024 Jan; 66(1):82-86. View Association between lower limb spasticity and cryptorchidism in males with cerebral palsy. Abstract
Mendelian etiologies identified with whole exome sequencing in cerebral palsy. Ann Clin Transl Neurol. 2022 02; 9(2):193-205. View Mendelian etiologies identified with whole exome sequencing in cerebral palsy. Abstract
Exercise to enhance neurocognitive function after traumatic brain injury. PM R. 2012 Nov; 4(11):908-13. View Exercise to enhance neurocognitive function after traumatic brain injury. Abstract
Exercise, sports participation, and musculoskeletal disorders of pregnancy and postpartum. Semin Neurol. 2011 Sep; 31(4):413-22. View Exercise, sports participation, and musculoskeletal disorders of pregnancy and postpartum. Abstract
Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancer. Anticancer Res. 2011 Apr; 31(4):1417-20. View Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancer. Abstract
Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies. BMC Cancer. 2010 Jul 14; 10:368. View Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies. Abstract
Portal hypertension associated with oxaliplatin administration: clinical manifestations of hepatic sinusoidal injury. Clin Colorectal Cancer. 2009 Oct; 8(4):225-30. View Portal hypertension associated with oxaliplatin administration: clinical manifestations of hepatic sinusoidal injury. Abstract
Emerging drugs for colorectal cancer. Expert Opin Emerg Drugs. 2008 Dec; 13(4):629-42. View Emerging drugs for colorectal cancer. Abstract
Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol. 2008 Nov 20; 26(33):5344-51. View Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. Abstract
Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma. Cancer. 2008 Oct 15; 113(8):2038-45. View Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma. Abstract
Aggressive combined modality therapy for recurrent colorectal cancer involving the duodenum and pancreas: a report of 5 cases. Clin Colorectal Cancer. 2008 Sep; 7(5):338-42. View Aggressive combined modality therapy for recurrent colorectal cancer involving the duodenum and pancreas: a report of 5 cases. Abstract
The gemcitabine, docetaxel, and capecitabine (GTX) regimen for metastatic pancreatic cancer: a retrospective analysis. Cancer Chemother Pharmacol. 2008 Jan; 61(1):167-75. View The gemcitabine, docetaxel, and capecitabine (GTX) regimen for metastatic pancreatic cancer: a retrospective analysis. Abstract
Androgen and c-Kit receptors in desmoplastic small round cell tumors resistant to chemotherapy: novel targets for therapy. Cancer Chemother Pharmacol. 2007 Mar; 59(4):429-37. View Androgen and c-Kit receptors in desmoplastic small round cell tumors resistant to chemotherapy: novel targets for therapy. Abstract
The evolution of adjuvant and neoadjuvant chemotherapy and radiation for advanced pancreatic cancer: from 5-fluorouracil to GTX. Surg Oncol Clin N Am. 2004 Oct; 13(4):711-35, x. View The evolution of adjuvant and neoadjuvant chemotherapy and radiation for advanced pancreatic cancer: from 5-fluorouracil to GTX. Abstract

Most people, no matter how many physicians they need to see, spend an overwhelming majority of their time working, playing, and living their lives outside of the doctor’s office. As a practitioner of Physical Medicine and Rehabilitation, I am responsible for helping my patients define their relationships with their lives outside of the time they spend in my direct care.

It is an honor, a privilege, and above all a great adventure to work with children and adolescents with special needs. Underlying all that I do is the fundamental belief that all kids of any age and any level of ability deserve the opportunity to laugh, play, and cause some trouble. I know I can help with that.